groupH
  • About Us
    • How We Work With You
    • Values
    • History
  • Team
  • Services
    • Decisions We Inform
    • Forecasting Event
  • Tools
    • Devil’s Advocate Tool
    • Gross-to-Net Tool (US)
    • Inflation Reduction Act (IRA) Tool
    • MAPPI Tool
    • Peak Share Tool
    • US Pricing Tool
  • Our Work
    • view by Therapy Area
    • view by Our Services
  • How We Work
  • Clients
  • Insights
  • News & Events
  • Careers
  • Contact Us
  • Menu Menu

groupH seasonal gathering 2018

21st December 2018/in News

At the close of a very busy last month of the year the groupH team got together at Berry Bros. & Rudd, Britain’s oldest wine and spirit merchant, in London’s St James’s. Deep underground in one of their cosy cellars, it was a great opportunity to connect with colleagues, old and new and to enjoy a selection of Old World wines for a couple of hours.

groupH wishes you all a Happy Christmas and Happy Holidays. We are closing our office for a short while to recharge our batteries and spend some time with family and friends.

We look forward to serving you again in 2019.

https://grouph.com/wp-content/uploads/2017/02/News_P.jpg 230 290 groupH https://grouph.com/wp-content/uploads/2022/03/GrouoH-logo-master.png groupH2018-12-21 08:51:372019-01-04 11:32:33groupH seasonal gathering 2018

EU Payer Opinion on Assessing Value in Rare Diseases

3rd December 2018/in Interview

groupH asked senior EU payers to comment on how they assess Value in Rare Diseases and how it is different from more prevalent indications.

Click below to watch one of the interviews, with Bruno Falissard.  Bruno is a former member of the Transparency Commission at HAS, Psychiatrist and Biostatistician, and Head of Research Unit Inserm U669 on Eating Disorders in Teenagers.

 

http://grouph.com.cpweb6.temporarywebsiteaddress.com/wp-content/uploads/2018/12/Reimbursment-rare-diseases-Falissard-final.mp4
https://grouph.com/wp-content/uploads/2017/02/Interview_P.jpg 230 290 groupH https://grouph.com/wp-content/uploads/2022/03/GrouoH-logo-master.png groupH2018-12-03 14:36:122018-12-03 18:07:39EU Payer Opinion on Assessing Value in Rare Diseases

Two countries divided by a common language?

3rd December 2018/in Comment

groupH explored the different approaches and philosophies behind Market Research and Consulting from the perspective of individuals with a Market Research, Strategy Consulting and Pharma background through a short online survey.

Please find the results and insights and a graphic showing how the MR and Consulting value chain, capabilities, project types and underlying value driving philosophies relate to each other informed by the findings.

groupH Survey Feedback

https://grouph.com/wp-content/uploads/2015/11/Comment_P.jpg 230 290 groupH https://grouph.com/wp-content/uploads/2022/03/GrouoH-logo-master.png groupH2018-12-03 13:59:532022-02-10 19:53:59Two countries divided by a common language?

Looking for and Quantifying Value in Rare Diseases: 6th November, 2018

3rd December 2018/in Events

groupH was selected to present on the topic of Looking for and Quantifying Value in Rare Diseases at an EphMRA meeting in Basel on 6th November, 2018.

Rare diseases present a number of challenges for manufacturers, which are absent in more prevalent conditions.  So which approach should you take when trying to determine value?

In his presentation Erik Holzinger addresses this question and highlights some of the issues involved.

Click here to view this presentation.

https://grouph.com/wp-content/uploads/2017/02/Event_P.jpg 230 290 groupH https://grouph.com/wp-content/uploads/2022/03/GrouoH-logo-master.png groupH2018-12-03 13:30:092022-02-10 20:12:34Looking for and Quantifying Value in Rare Diseases: 6th November, 2018

Pages

  • Devil’s Advocate Tool
  • Download Form
  • Download270319
  • Gross-to-Net (US) Tool
  • History
  • Home
  • Inflation Reduction Act Tool
  • Peak Share Tool
  • Tools
  • US Pricing Tool
  • About Us
  • Decisions We Inform
  • How We Work With You
  • Therapy Area
  • Service Offering
  • Team
  • Values
  • Forecasting Event
  • Services
  • MAPPI Tool
  • Our Work
  • Clients
  • How We Work
  • Our Insights
  • News & Events
  • Contact us
  • Register
  • Careers
  • Cookie Policy
  • Privacy Policy
  • Sitemap
  • Terms & Conditions
  • Training Terms & Conditions

Categories

  • Autoimmune
  • Briefing Note
  • Careers
  • CNS
  • Comment
  • Competitor workshops
  • Demand assessments
  • Dermatology
  • Disease area strategy
  • Events
  • Infectious Disesases
  • Inspiration
  • Interview
  • Market landscaping
  • New Horizons
  • News
  • Oncology
  • Scenario planning workshops
  • Team
  • TPP shaping and validation
  • Uncategorised
  • White Papers

Archive

  • May 2026
  • December 2025
  • August 2025
  • April 2025
  • February 2025
  • December 2024
  • October 2024
  • September 2024
  • June 2024
  • May 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • June 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • July 2022
  • April 2022
  • January 2022
  • October 2021
  • September 2021
  • August 2021
  • June 2021
  • May 2021
  • January 2021
  • December 2020
  • October 2020
  • June 2020
  • May 2020
  • December 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • March 2019
  • December 2018
  • September 2018
  • August 2018
  • May 2018
  • December 2017
  • October 2017
  • September 2017
  • June 2017
  • May 2017
  • December 2016
  • November 2016
  • October 2016
  • May 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • June 2015
  • April 2015
  • March 2015
  • December 2014
  • September 2014
  • November 2013
  • July 2013
  • June 2013
  • April 2013
  • March 2013
  • February 2013
  • December 2012
  • November 2012
  • September 2012
  • February 2012
  • December 2010

© groupH Ltd

LinkedIn
newsletter
Vimeo

  • Contact us
  • Tools
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Sitemap
Scroll to top Scroll to top Scroll to top
By continuing to use this website you will be agreeing to our Terms & Conditions, our Privacy Policy, and the use of cookies.